- Home
- VSCO vs MNKD Comparison
VSCO vs MNKD Comparison
Compare VSCO & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSCO
- MNKD
- Stock Information
- Founded
- VSCO 1977
- MNKD 1991
- Country
- VSCO United States
- MNKD United States
- Employees
- VSCO N/A
- MNKD N/A
- Industry
- VSCO Clothing/Shoe/Accessory Stores
- MNKD Biotechnology: Pharmaceutical Preparations
- Sector
- VSCO Consumer Discretionary
- MNKD Health Care
- Exchange
- VSCO Nasdaq
- MNKD Nasdaq
- Market Cap
- VSCO 2.1B
- MNKD 1.7B
- IPO Year
- VSCO N/A
- MNKD 2004
- Fundamental
- Price
- VSCO $31.37
- MNKD $5.51
- Analyst Decision
- VSCO Hold
- MNKD Strong Buy
- Analyst Count
- VSCO 12
- MNKD 5
- Target Price
- VSCO $26.50
- MNKD $10.80
- AVG Volume (30 Days)
- VSCO 2.0M
- MNKD 4.6M
- Earning Date
- VSCO 12-04-2025
- MNKD 11-06-2025
- Dividend Yield
- VSCO N/A
- MNKD N/A
- EPS Growth
- VSCO 6.76
- MNKD 149.32
- EPS
- VSCO 1.86
- MNKD 0.11
- Revenue
- VSCO $6,265,000,000.00
- MNKD $301,736,000.00
- Revenue This Year
- VSCO $4.67
- MNKD $16.36
- Revenue Next Year
- VSCO $2.67
- MNKD $20.34
- P/E Ratio
- VSCO $16.90
- MNKD $50.92
- Revenue Growth
- VSCO 2.29
- MNKD 21.48
- 52 Week Low
- VSCO $13.76
- MNKD $3.38
- 52 Week High
- VSCO $48.73
- MNKD $7.63
- Technical
- Relative Strength Index (RSI)
- VSCO 67.71
- MNKD 56.12
- Support Level
- VSCO $29.65
- MNKD $5.21
- Resistance Level
- VSCO $31.34
- MNKD $5.58
- Average True Range (ATR)
- VSCO 1.33
- MNKD 0.26
- MACD
- VSCO 0.09
- MNKD -0.02
- Stochastic Oscillator
- VSCO 84.73
- MNKD 65.16
About VSCO Victorias Secret & Co.
Victoria's Secret & Co is a retailer of women's intimate and other apparel and beauty products marketed under the Victoria's Secret, PINK, and Adore Me brand names. It also includes the merchandise sourcing and production function serving the Company and its international partners. The Company operates as a single segment designed to serve customers seamlessly through stores and online channels.
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.